MSCI World SRI Climate Net Zero Ambition PAB UCITS ETF News - MWSH

LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China

NATICK, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- LipimetiX Development, Inc. (“LipimetiX” or “the Company”...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________ FORM 8-K CURRENT REPORT Pursuant...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; Pulmon

TEMPE, Ariz., July 6, 2011 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) (the "Company") today...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________ FORM 8-K CURRENT REPORT Pursuant...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________ FORM 8-K CURRENT REPORT Pursuant...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________ FORM 8-K CURRENT REPORT Pursuant...

- Amended Securities Registration (section 12(b)) (8-A12B/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A AMENDMENT NO. 3 FOR REGISTRATION OF CERTAIN...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________ FORM 8-K CURRENT REPORT Pursuant...

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________ SCHEDULE 14A (RULE 14A –...

Capstone Therapeutics Announces Adjournment of Its Annual Meeting of Stockholders and Intention to Reconvene the Meeting on June

TEMPE, Ariz., June 8, 2011 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) (the "Company") announced...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________ FORM 8-K CURRENT REPORT Pursuant...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

MSCI World SRI Climate Net Zero Ambition PAB UCITS ETF (MWSH)

Empower your portfolio: Real-time discussions and actionable trading ideas.

MWSH News

LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China

- Current report filing (8-K)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; Pulmon

- Statement of Changes in Beneficial Ownership (4)

- Current report filing (8-K)

- Statement of Changes in Beneficial Ownership (4)

- Current report filing (8-K)

- Current report filing (8-K)

- Amended Securities Registration (section 12(b)) (8-A12B/A)

- Current report filing (8-K)

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

Capstone Therapeutics Announces Adjournment of Its Annual Meeting of Stockholders and Intention to Reconvene the Meeting on June

- Current report filing (8-K)

MWSH Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

MSCI World SRI Climate Net Zero Ambition PAB UCITS ETF (MWSH) News

MSCI World SRI Climate Net Zero Ambition PAB UCITS ETF (MWSH)

Empower your portfolio: Real-time discussions and actionable trading ideas.

MWSH News

LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China

- Current report filing (8-K)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; Pulmon

- Statement of Changes in Beneficial Ownership (4)

- Current report filing (8-K)

- Statement of Changes in Beneficial Ownership (4)

- Current report filing (8-K)

- Current report filing (8-K)

- Amended Securities Registration (section 12(b)) (8-A12B/A)

- Current report filing (8-K)

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

Capstone Therapeutics Announces Adjournment of Its Annual Meeting of Stockholders and Intention to Reconvene the Meeting on June

- Current report filing (8-K)

MWSH Discussion

Your Recent History